RET kinase inhibitors

Disclosed herein are compounds of formula I: or a pharmaceutically acceptable salt thereof, where the variables are as defined herein. These compounds are useful in treating RET associated cancers. Formulations containing the compounds of formula I and methods of making the compounds of formula I ar...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	BOLDRON, CHRISTOPHER PIERRE ALBERT JEAN, MOURET, TIPHAINE, PANCALDI, THOMAS PIERRE DINO, ANDREWS, STEVEN W, MCKENNEY, MEGAN L, PILKINGTON-MIKSA, MICHAEL ALEXANDER, IRVIN, THOMAS C, ANDERSON, ERIN D, MCFADDIN, ELIZABETH A, MUNCHHOF, MICHAEL J, CONDROSKI, KEVIN R, PINTO, MARTA, MCLEAN, JOHNATHAN ALEXANDER, KOLAKOWSKI, GABRIELLE R, KUMAR, MANOJ
Format:	Patent
Sprache:	chi ; eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Disclosed herein are compounds of formula I: or a pharmaceutically acceptable salt thereof, where the variables are as defined herein. These compounds are useful in treating RET associated cancers. Formulations containing the compounds of formula I and methods of making the compounds of formula I are also disclosed.